|
US1724052A
(en)
|
1928-06-13 |
1929-08-13 |
Luther S Swearengin |
Fire-door construction
|
|
US5034506A
(en)
|
1985-03-15 |
1991-07-23 |
Anti-Gene Development Group |
Uncharged morpholino-based polymers having achiral intersubunit linkages
|
|
US5283058A
(en)
|
1990-08-30 |
1994-02-01 |
The General Hospital Corporation |
Methods for inhibiting rejection of transplanted tissue
|
|
EP0555428A1
(en)
|
1991-07-30 |
1993-08-18 |
Baxter International Inc. |
Foramenous implant
|
|
US7101543B2
(en)
|
2000-03-31 |
2006-09-05 |
Novarx |
Genetically modified cells expressing a TGFβ inhibitor, the cells being lung cancer cells
|
|
JP2004514407A
(ja)
|
2000-04-28 |
2004-05-20 |
ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
異種キャプシド中にシュードタイピングされたａａｖ５キャプシドおよびａａｖ５ベクターを含む組換えａａｖベクター
|
|
US20060222633A1
(en)
|
2000-05-11 |
2006-10-05 |
Yale University |
Prevention, decrease, and/or treatment of immunoreactivity by depleting and/or inactivating antigen presenting cells in the host
|
|
US6635750B1
(en)
|
2000-07-20 |
2003-10-21 |
Millennium Pharmaceuticals, Inc. |
B7-H2 nucleic acids, members of the B7 family
|
|
US7432104B2
(en)
|
2001-08-06 |
2008-10-07 |
Bresgen Inc. |
Methods for the culture of human embryonic stem cells on human feeder cells
|
|
EP2722387B1
(en)
|
2003-12-23 |
2019-12-11 |
Viacyte, Inc. |
Definitive endoderm
|
|
US8586357B2
(en)
|
2003-12-23 |
2013-11-19 |
Viacyte, Inc. |
Markers of definitive endoderm
|
|
US20050266554A1
(en)
|
2004-04-27 |
2005-12-01 |
D Amour Kevin A |
PDX1 expressing endoderm
|
|
US7985585B2
(en)
|
2004-07-09 |
2011-07-26 |
Viacyte, Inc. |
Preprimitive streak and mesendoderm cells
|
|
US7541185B2
(en)
|
2003-12-23 |
2009-06-02 |
Cythera, Inc. |
Methods for identifying factors for differentiating definitive endoderm
|
|
US8187878B2
(en)
|
2004-08-13 |
2012-05-29 |
University Of Georgia Research Foundation, Inc. |
Methods for increasing definitive endoderm differentiation of pluripotent human embryonic stem cells with PI-3 kinase inhibitors
|
|
EP2110667A1
(en)
|
2005-01-20 |
2009-10-21 |
University Of Rochester |
Thoredoxin interacting protein (TXNIP) as regulator of vascular function
|
|
ES2687233T3
(es)
|
2005-10-27 |
2018-10-24 |
Viacyte, Inc. |
Endodermo de intestino proximal dorsal y ventral que expresa PDX-1
|
|
EP2420565B1
(en)
|
2006-02-23 |
2017-08-30 |
ViaCyte, Inc. |
Compositions and methods useful for culturing differentiable cells
|
|
NZ571427A
(en)
|
2006-03-02 |
2012-07-27 |
Viacyte Inc |
Endocrine precursor cells, pancreatic hormone-expressing cells and methods of production
|
|
US7695965B2
(en)
|
2006-03-02 |
2010-04-13 |
Cythera, Inc. |
Methods of producing pancreatic hormones
|
|
WO2007139929A2
(en)
|
2006-05-25 |
2007-12-06 |
The Burnham Institute For Medical Research |
Methods for culture and production of single cell populations of human embryonic stem cells
|
|
RU2473685C2
(ru)
|
2007-07-31 |
2013-01-27 |
Лайфскен, Инк. |
Дифференцировка человеческих эмбриональных стволовых клеток
|
|
US7695963B2
(en)
|
2007-09-24 |
2010-04-13 |
Cythera, Inc. |
Methods for increasing definitive endoderm production
|
|
US8623650B2
(en)
|
2007-10-19 |
2014-01-07 |
Viacyte, Inc. |
Methods and compositions for feeder-free pluripotent stem cell media containing human serum
|
|
CN107574142B
(zh)
|
2007-11-27 |
2021-07-06 |
生命扫描有限公司 |
人胚胎干细胞的分化
|
|
US8338170B2
(en)
|
2008-04-21 |
2012-12-25 |
Viacyte, Inc. |
Methods for purifying endoderm and pancreatic endoderm cells derived from human embryonic stem cells
|
|
US7939322B2
(en)
|
2008-04-24 |
2011-05-10 |
Centocor Ortho Biotech Inc. |
Cells expressing pluripotency markers and expressing markers characteristic of the definitive endoderm
|
|
US20120058105A1
(en)
|
2008-06-27 |
2012-03-08 |
Martin Kean Chong Ng |
Method of treatment of vascular complications
|
|
EP2346988B1
(en)
|
2008-10-31 |
2017-05-31 |
Janssen Biotech, Inc. |
Differentiation of human embryonic stem cells to the pancreatic endocrine lineage
|
|
JP2012507289A
(ja)
|
2008-10-31 |
2012-03-29 |
ヤンセン バイオテツク，インコーポレーテツド |
ヒト胚性幹細胞の膵内分泌系への分化
|
|
US8008075B2
(en)
|
2008-11-04 |
2011-08-30 |
Viacyte, Inc. |
Stem cell aggregate suspension compositions and methods of differentiation thereof
|
|
US8895300B2
(en)
|
2008-11-04 |
2014-11-25 |
Viacyte, Inc. |
Scalable primate pluripotent stem cell aggregate suspension culture and differentiation thereof
|
|
EP2356227B1
(en)
|
2008-11-14 |
2018-03-28 |
Viacyte, Inc. |
Encapsulation of pancreatic cells derived from human pluripotent stem cells
|
|
US20100272710A1
(en)
|
2009-03-26 |
2010-10-28 |
Abdelhadi Rebbaa |
Compositions and methods for treating and preventing aging-associated diseases
|
|
ES2849181T3
(es)
|
2009-04-22 |
2021-08-16 |
Viacyte Inc |
Composiciones celulares derivadas de células reprogramadas desdiferenciadas
|
|
US9109245B2
(en)
|
2009-04-22 |
2015-08-18 |
Viacyte, Inc. |
Cell compositions derived from dedifferentiated reprogrammed cells
|
|
WO2010129294A2
(en)
|
2009-04-27 |
2010-11-11 |
Schulz Thomas C |
Small molecules supporting pluripotent cell growth and methods thereof
|
|
EP2456858B1
(en)
|
2009-07-20 |
2018-08-29 |
Janssen Biotech, Inc. |
Differentiation of human embryonic stem cells
|
|
RU2540016C2
(ru)
|
2009-07-20 |
2015-01-27 |
Янссен Байотек, Инк. |
Дифференцировка эмбриональных стволовых клеток человека
|
|
RU2664864C1
(ru)
|
2009-12-23 |
2018-08-23 |
Янссен Байотек, Инк. |
Способы увеличения экспрессии ngn3 и nkx6.1 в эндокринных клетках поджелудочной железы
|
|
DK2516625T3
(da)
|
2009-12-23 |
2024-09-09 |
Janssen Biotech Inc |
Differentiering af humane embryonale stamceller
|
|
KR101836850B1
(ko)
|
2010-08-31 |
2018-03-09 |
얀센 바이오테크 인코포레이티드 |
인간 배아 줄기 세포의 분화
|
|
WO2012030540A2
(en)
|
2010-08-31 |
2012-03-08 |
Janssen Biotech, Inc. |
Differentiation of pluripotent stem cells
|
|
JP5875597B2
(ja)
|
2010-12-08 |
2016-03-02 |
ヴィアサイト，インコーポレイテッド |
ヒト万能性幹細胞の成長を阻害する薬剤および方法
|
|
DK2699593T4
(da)
|
2011-04-20 |
2021-02-08 |
Univ Washington Through Its Center For Commercialization |
Beta-2 mikroglobulin-deficiente celler
|
|
USD726306S1
(en)
|
2011-12-12 |
2015-04-07 |
Viacyte, Inc. |
Cell encapsulation device
|
|
USD728095S1
(en)
|
2011-12-12 |
2015-04-28 |
Viacyte, Inc. |
Cell encapsulation device
|
|
USD726307S1
(en)
|
2011-12-12 |
2015-04-07 |
Viacyte Inc. |
Cell encapsulation device
|
|
ES2923757T3
(es)
|
2011-12-16 |
2022-09-30 |
Modernatx Inc |
Composiciones de ARNm modificado
|
|
RU2705001C2
(ru)
|
2011-12-22 |
2019-11-01 |
Янссен Байотек, Инк. |
Дифференцировка эмбриональных стволовых клеток человека в одногормональные инсулинположительные клетки
|
|
DK2657340T3
(en)
|
2012-04-25 |
2017-02-27 |
Deutsches Krebsforsch |
Thioredoxin-interacting protein (TXNIP) inhibitors for therapy
|
|
US20140162359A1
(en)
|
2012-05-07 |
2014-06-12 |
Janssen Biotech, Inc. |
Differentiation of Human Embryonic Stem Cells into Pancreatic Endoderm
|
|
ES2728782T3
(es)
|
2012-05-25 |
2019-10-28 |
Univ California |
Métodos y composiciones para la modificación de ADN objetivo dirigida por ARN y para la modulación de la transcripción dirigida por ARN
|
|
USD734847S1
(en)
|
2012-05-31 |
2015-07-21 |
Viacyte, Inc. |
Cell encapsulation device
|
|
CN104334719B
(zh)
|
2012-06-08 |
2018-02-13 |
詹森生物科技公司 |
人胚胎干细胞向胰腺内分泌细胞的分化
|
|
RU2015100900A
(ru)
|
2012-06-14 |
2016-08-10 |
Янссен Байотек, Инк. |
Обработка плюрипотентных клеток
|
|
MX380562B
(es)
|
2012-12-12 |
2025-03-12 |
Broad Inst Inc |
Modificaciones de sistemas, métodos y composiciones guía optimizadas para la manipulación de secuencias.
|
|
US10370644B2
(en)
|
2012-12-31 |
2019-08-06 |
Janssen Biotech, Inc. |
Method for making human pluripotent suspension cultures and cells derived therefrom
|
|
DK2938722T3
(da)
|
2012-12-31 |
2022-02-14 |
Janssen Biotech Inc |
Suspension og klyngedannelse af humane pluripotente celler til differentiering til endokrine pankreasceller
|
|
MX2015008578A
(es)
|
2012-12-31 |
2015-09-07 |
Janssen Biotech Inc |
Diferenciacion de celulas madre embrionarias humanas en celulas endocrinas pancreaticas mediante el uso de relugadores de hb9.
|
|
KR102084561B1
(ko)
|
2012-12-31 |
2020-03-04 |
얀센 바이오테크 인코포레이티드 |
췌장 내분비 세포로의 분화를 위한 공기-액체 계면에서의 인간 배아 줄기세포의 배양
|
|
USD720469S1
(en)
|
2013-03-07 |
2014-12-30 |
Viacyte, Inc. |
Cell encapsulation device
|
|
JP6234485B2
(ja)
|
2013-03-07 |
2017-11-22 |
ヴィアサイト インコーポレイテッド |
３次元大収容力細胞封入デバイスアセンブリー
|
|
US8859286B2
(en)
|
2013-03-14 |
2014-10-14 |
Viacyte, Inc. |
In vitro differentiation of pluripotent stem cells to pancreatic endoderm cells (PEC) and endocrine cells
|
|
US9101597B2
(en)
|
2013-03-14 |
2015-08-11 |
The Administration Of The Tulane Educational Fund |
Immunoprotective primary mesenchymal stem cells and methods
|
|
WO2014195159A1
(en)
|
2013-06-03 |
2014-12-11 |
Theravectys |
Lentiviral vectors containing an mhc class i, mhc class ii, or beta-2 microglobulin upstream promoter sequence
|
|
AU2014278178B2
(en)
|
2013-06-11 |
2021-01-21 |
President And Fellows Of Harvard College |
SC-beta cells and compositions and methods for generating the same
|
|
KR20140144964A
(ko)
|
2013-06-12 |
2014-12-22 |
한국생명공학연구원 |
티오레독신-결합 단백질을 유효성분으로 포함하는 약학적 조성물 및 이의 용도
|
|
KR20250012194A
(ko)
|
2013-06-17 |
2025-01-23 |
더 브로드 인스티튜트, 인코퍼레이티드 |
바이러스 구성성분을 사용하여 장애 및 질환을 표적화하기 위한 crispr-cas 시스템 및 조성물의 전달, 용도 및 치료 적용
|
|
RU2689710C2
(ru)
|
2013-11-01 |
2019-05-29 |
Янссен Байотек, Инк. |
Суспендирование и кластеризация плюрипотентных стволовых клеток человека с целью их дифференцировки в панкреатические эндокринные клетки
|
|
USD718472S1
(en)
|
2014-03-07 |
2014-11-25 |
Viacyte, Inc. |
3-dimensional large capacity cell encapsulation device
|
|
USD718469S1
(en)
|
2014-03-07 |
2014-11-25 |
Viacyte, Inc. |
3-dimensional large capacity cell encapsulation device
|
|
USD718471S1
(en)
|
2014-03-07 |
2014-11-25 |
Viacyte, Inc. |
3-dimensional large capacity cell encapsulation device
|
|
USD718466S1
(en)
|
2014-03-07 |
2014-11-25 |
Viacyte, Inc. |
3-Dimensional large capacity cell encapsulation device
|
|
USD718467S1
(en)
|
2014-03-07 |
2014-11-25 |
Viacyte, Inc. |
3-dimensional large capacity cell encapsulation device
|
|
USD718468S1
(en)
|
2014-03-07 |
2014-11-25 |
Viacyte, Inc. |
3-dimensional large capacity cell encapsulation device
|
|
USD718470S1
(en)
|
2014-03-07 |
2014-11-25 |
Viacyte, Inc. |
3-dimensional large capacity cell encapsulation device
|
|
USD714956S1
(en)
|
2014-03-07 |
2014-10-07 |
Viacyte, Inc. |
3-dimensional large capacity cell encapsulation device
|
|
RU2752933C2
(ru)
|
2014-03-11 |
2021-08-11 |
Селлектис |
Способ создания т-клеток, пригодных для аллогенной трансплантации
|
|
EP3122370A1
(en)
|
2014-03-28 |
2017-02-01 |
Buck Institute for Research on Aging |
Methods and compositions for modulating the immune system
|
|
USD761424S1
(en)
|
2014-04-16 |
2016-07-12 |
Viacyte, Inc. |
Deployment tool for an encapsulation device
|
|
USD761423S1
(en)
|
2014-04-16 |
2016-07-12 |
Viacyte, Inc. |
Sizing tool for an encapsulation device
|
|
USD760399S1
(en)
|
2014-04-16 |
2016-06-28 |
Viacyte, Inc. |
Case for an encapsulation device
|
|
USD734166S1
(en)
|
2014-04-16 |
2015-07-14 |
Viacyte, Inc. |
Fill pouch assembly for encapsulation device
|
|
SG11201609473XA
(en)
|
2014-05-16 |
2016-12-29 |
Janssen Biotech Inc |
Use of small molecules to enhance mafa expression in pancreatic endocrine cells
|
|
WO2016073955A2
(en)
|
2014-11-06 |
2016-05-12 |
President And Fellows Of Harvard College |
Cells lacking b2m surface expression and methods for allogeneic administration of such cells
|
|
CN107250349A
(zh)
|
2014-12-19 |
2017-10-13 |
詹森生物科技公司 |
多能干细胞的悬浮培养
|
|
EP3294342A4
(en)
*
|
2015-05-08 |
2018-11-07 |
President and Fellows of Harvard College |
Universal donor stem cells and related methods
|
|
EP4339287A3
(en)
|
2015-07-31 |
2024-05-22 |
Regents Of The University Of Minnesota |
Modified cells and methods of therapy
|
|
US12642852B1
(en)
*
|
2015-11-04 |
2026-06-02 |
Fate Therapeutics, Inc. |
Genomic engineering of pluripotent cells
|
|
CA3027879A1
(en)
|
2016-06-21 |
2017-12-28 |
Janssen Biotech, Inc. |
Generation of human pluripotent stem cell derived functional beta cells showing a glucose-dependent mitochondrial respiration and two-phase insulin secretion response
|
|
WO2018035387A1
(en)
|
2016-08-17 |
2018-02-22 |
The Broad Institute, Inc. |
Novel crispr enzymes and systems
|
|
US9982267B2
(en)
|
2016-10-12 |
2018-05-29 |
Feldan Bio Inc. |
Rationally-designed synthetic peptide shuttle agents for delivering polypeptide cargos from an extracellular space to the cytosol and/or nucleus of a target eukaryotic cell, uses thereof, methods and kits relating to same
|
|
EP4595951A3
(en)
|
2016-11-10 |
2025-08-27 |
ViaCyte, Inc. |
Pdx1 pancreatic endoderm cells in cell delivery devices
|
|
KR20240095477A
(ko)
|
2017-01-13 |
2024-06-25 |
더 리젠츠 오브 더 유니버시티 오브 캘리포니아 |
면역조작된 만능 세포
|
|
EP3596117A4
(en)
|
2017-03-17 |
2021-01-13 |
The Johns Hopkins University |
TARGETED EPIGENETIC THERAPY AGAINST THE DISTAL EXPRESSION REGULATORY ELEMENT OF TGFB2
|
|
CN110869494B
(zh)
|
2017-06-12 |
2025-02-18 |
西奈卫生系统公司 |
无需全身性免疫遏制的同种异体移植物耐受
|
|
US10391156B2
(en)
|
2017-07-12 |
2019-08-27 |
Viacyte, Inc. |
University donor cells and related methods
|
|
JP7621795B2
(ja)
|
2017-10-19 |
2025-01-27 |
セレクティス |
改善された免疫細胞療法のためのｎｋ阻害物質遺伝子の標的指向遺伝子組み込み
|
|
CN107723275B
(zh)
|
2017-10-20 |
2020-09-04 |
重庆精准生物技术有限公司 |
通用型car-t细胞及其制备方法和应用
|
|
SG11202004529XA
(en)
|
2017-11-16 |
2020-06-29 |
Mogam Inst Biomedical Res |
Transformed human cell and use thereof
|
|
CN111556892A
(zh)
|
2017-12-08 |
2020-08-18 |
菲特治疗公司 |
使用增强的iPSC衍生的效应细胞的免疫疗法
|
|
US20190223416A1
(en)
|
2018-01-23 |
2019-07-25 |
Cotyledon, LLC |
Canine genome editing
|
|
EP3754018A4
(en)
|
2018-02-16 |
2021-11-24 |
Kyoto University |
METHOD OF MANUFACTURING A WEAK ANTIGENT CELL
|
|
US12378572B2
(en)
|
2018-09-07 |
2025-08-05 |
Crispr Therapeutics Ag |
Universal donor cells
|
|
CA3120576A1
(en)
|
2018-11-26 |
2020-06-04 |
Massachusetts Institute Of Technology |
Compositions and methods for immune tolerance
|
|
CA3123102A1
(en)
|
2018-12-13 |
2020-06-18 |
Sinai Health System |
Immunomodulatory cells and uses thereof
|
|
WO2020206055A1
(en)
|
2019-04-02 |
2020-10-08 |
Yale University |
Methods of treatment of diseases and disorders associated with increased tet level, increased h19 level, increased level of tgf signaling, or any combination thereof
|
|
US20220213434A1
(en)
*
|
2019-05-10 |
2022-07-07 |
The Regents Of The University Of California |
Modified pluripotent cells
|
|
WO2020228039A1
(en)
|
2019-05-16 |
2020-11-19 |
Egenesis, Inc. |
Cells, tissues, organs, and/or animals having one or more modified genes for enhanced xenograft survival and/or tolerance
|
|
CN110373389A
(zh)
*
|
2019-06-10 |
2019-10-25 |
云南农业大学 |
一种适合胰岛细胞及皮肤等组织异种移植供体猪的构建方法
|
|
US11116798B2
(en)
|
2019-09-05 |
2021-09-14 |
Crispr Therapeutics Ag |
Universal donor cells
|
|
US11104918B2
(en)
|
2019-09-05 |
2021-08-31 |
Crispr Therapeutics Ag |
Universal donor cells
|
|
US11566230B2
(en)
|
2020-12-31 |
2023-01-31 |
Crispr Therapeutics Ag |
Universal donor cells
|